Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Risk Management and Healthcare Policy|December 8, 2021
Perceptions of Adolescents and Health Workers Towards Adolescents' TB Diagnosis in Central Uganda: A Cross-Sectional Qualitative StudyWinters Muttamba, Mudarshiru Bbuye, Joseph Baruch Baluku, et al.International Journal of Burns and Trauma|July 27, 2022
Incidence and risk factors of acute kidney injury in severely burned patients in Mulago Hospital, Uganda - a prospective cohortJoel Wandabwa, Robert Kalyesubula, Irene Najjingo, et al.Therapeutic Advances in Infectious Disease|March 26, 2026
Chronic pulmonary aspergillosis and pulmonary embolism/venous thromboembolism: a case series and systematic review of the literatureJoseph Baruch Baluku, Peter Isagara, Ivaan Pitua, et al.Plos One|May 16, 2019
Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional studyIrene Najjingo, Winters Muttamba, Bruce J Kirenga, et al.BMJ Open Respiratory Research|March 15, 2024
Characteristics and phenotypes of a COPD cohort from referral hospital clinics in UgandaPatricia Alupo, Levicatus Mugenyi, Winceslaus Katagira, et al.Tuberculosis Research and Treatment|April 8, 2021
Accuracy and Incremental Yield of the Chest X-Ray in Screening for Tuberculosis in Uganda: A Cross-Sectional StudyJoanitah Nalunjogi, Frank Mugabe, Irene Najjingo, et al.Open Forum Infectious Diseases|June 30, 2021
Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in UgandaWilly Ssengooba, Jean de Dieu Iragena, Kevin Komakech, et al.BMC Cardiovascular Disorders|November 5, 2022
Cardiovascular risk factors among people with drug-resistant tuberculosis in UgandaJoseph Baruch Baluku, Martin Nabwana, Joanitah Nalunjogi, et al.Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 24, 2021
Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from UgandaWilly Ssengooba, Kevin Komakech, Sharon Namiiro, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 18, 2024
The Neutrophil-to-Lymphocyte Ratio as a Predictor of Acute Exacerbations Among Patients With COPD in UgandaPatricia Alupo, Winceslaus Katagira, David Mukunya, et al.Pageof 2